PDS Biotechnology Corp
PDSB · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Dawson John Andrew: Form 4
Insider disclosure · Filed · Report period 18 Oct 2026
-
Form 3
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- PDSB · 70465T107 - Common Stock, par value $0.00033 per share
Company details and SEC sources
CIK 0001472091 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- PDSB on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 303 A College Road East, Princeton, NJ, 08540
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- Edge Therapeutics, Inc. (to 18 Mar 2019)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields